Risk Factors for Pediatric Alopecia Areata: Clinical and Biochemical Findings from a Case – Control Study
Keywords:
alopecia areata , children, vitiligo, allergic astma, Attention Deficit Disorder with HyperactivityAbstract
Introduction: Alopecia areata (AA) is an immune-mediated, non-scarring hair loss disorder that can begin in childhood. Data on comorbidities and biochemical risk factors in pediatric AA remain limited.
Objectives: To compare clinical comorbidities and biochemical parameters in pediatric patients with AA versus healthy controls.
Methods: This retrospective, matched case-control study included 200 pediatric AA patients and 400 age- and sex-matched healthy controls. Clinical characteristics and comorbidities were obtained from patient records. Hemoglobin, ferritin, vitamin B12, and thyroid-stimulating hormone (TSH) levels were analyzed. Independent predictors were identified using multivariable logistic regression.
Results: Vitiligo (3.5% vs. 0.5%; P=0.008), allergic asthma (9.5% vs. 3.8%; P=0.007), and attention-deficit/hyperactivity disorder (ADHD) (3.5% vs. 0.5%; P=0.008) were significantly more frequent in the AA group, whereas atopic dermatitis was more common but not statistically significant. Hemoglobin levels were comparable. Serum vitamin B12 [233.5 (192.7–270.0) vs. 356.7 (318.7–396.8) pg/mL; P<0.001] and ferritin [14.4 (6.5–22.3) vs. 19.4 (11.6–27.0) ng/mL; P<0.001] were significantly lower, and TSH levels were also reduced (3.40 ± 1.48 vs. 3.71 ± 1.50 mIU/L; P=0.017). Multivariable analysis identified low vitamin B12 (OR = 0.964, 95% CI: 0.958–0.970; P<0.001) and low ferritin (OR = 0.965, 95% CI: 0.944–0.988; P=0.003) as independent risk factors.
Conclusions: Pediatric AA is associated with vitiligo, asthma, ADHD, and reduced levels of ferritin, vitamin B12, and TSH. These findings underscore the importance of comprehensive clinical and biochemical evaluation in pediatric AA.
References
Alessandrini A, Starace M, Bruni F,et al. Alopecia areata incognita and diffuse alopecia areata: clinical, trichoscopic, histopathological, and therapeutic features of a 5-year study. Dermatol Pract Concept. 2019;9(4):272-7. DOI: 10.5826/dpc.0904a05. PMID: 31723460; PMCID: PMC6830548.
Tabara K, Kozłowska M, Jędrowiak A, Bienias W, Kaszuba A. Serum concentrations of selected proinflammatory cytokines in children with alopecia areata. Postepy Dermatol Alergol. 2019;36(1):63-9. DOI: 10.5114/ada.2019.82826. PMID: 30858781
Minokawa Y, Sawada Y, Nakamura M. Lifestyle factors involved in the pathogenesis of alopecia areata. Int J Mol Sci. 2022;23(3):1038. DOI: 10.3390/ijms23031038. PMID: 35162962; PMCID: PMC8835065.
Prie BE, Voiculescu VM, Ionescu-Bozdog OB, et al. Oxidative stress and alopecia areata. J Med Life. 2015;8(Spec Issue):43-6. PMID: 26361510; PMCID: PMC4564047.
Kantor J, Kessler LJ, Brooks DG, Cotsarelis G. Decreased serum ferritin is associated with alopecia in women. J Invest Dermatol. 2003;121(5):985-8. DOI: 10.1046/j.1523-1747.2003.12540.x. PMID: 14708596
Chisti MA, Masood Q, Shah IH, et al. Serum ferritin levels in non-scarring alopecia of women: a case-control study. J Pak Assoc Dermatol. 2012;22:4-11.
Devaraj Y, Devi THB, Bachaspatimayum R. Correlation between serum ferritin and severity of alopecia areata. Indian J Clin Exp Dermatol. 2018;4(4):307-10. DOI: 10.18231/j.ijced.2019.070
Thompson JM, Mirza MA, Park MK, Qureshi AA, Cho E. The role of micronutrients in alopecia areata: a review. Am J Clin Dermatol. 2017;18(5):663-79. DOI: 10.1007/s40257-017-0285-x. PMID: 28508256; PMCID: PMC5685931.
Kincaid CM, Sharma AN, Mesinkovska NA. Alopecia areata is associated with risk of inflammatory arthritis. J Am Acad Dermatol. 2023;89(2):422-3. DOI: 10.1016/j.jaad.2023.04.039. PMID: 37121482
Gök AM, Aşkın Ö, Serdaroğlu S, Kutlubay Z. Retrospective analysis of the effect of comorbid atopic dermatitis on the treatment response to topical immunotherapy in pediatric alopecia areata patients. Dermatol Pract Concept. 2024;14(1):e2024006. DOI: 10.5826/dpc.1401a6. PMID: 38364396
Vélez-Muñiz RDC, Peralta-Pedrero ML, Jurado-Santa Cruz F, Morales-Sánchez MA. Psychological profile and quality of life of patients with alopecia areata. Skin Appendage Disord. 2019;5(5):293-8. DOI: 10.1159/000497166. PMID: 31559253; PMCID: PMC6751425.
Singam V, Patel KR, Lee HH, Rastogi S, Silverberg JI. Association of alopecia areata with hospitalization for mental health disorders in US adults. J Am Acad Dermatol. 2019;80(3):792-4. DOI: 10.1016/j.jaad.2018.07.044. PMID: 30092332.
Kuty-Pachecka M. Psychological and psychopathological factors in alopecia areata. Psychiatr Pol. 2015;49(5):955-64. DOI: 10.12740/PP/39064. PMID: 26688846.
Sibbald C. Alopecia areata: an updated review for 2023. J Cutan Med Surg. 2023;27(3):241-59. DOI: 10.1177/12034754231168839. PMID: 37340563
David E, Shokrian N, Del Duca E, et al. Dupilumab induces hair regrowth in pediatric alopecia areata: a real-world, single-center observational study. Arch Dermatol Res. 2024;316(7):487. DOI: 10.1007/s00403-024-03225-4. PMID: 39042295
Jang YH, Eun DH, Kim DW. Long-term prognosis of alopecia areata in children and adolescents. Ann Dermatol. 2019;31(2):231-4. DOI: 10.5021/ad.2019.31.2.231. PMID: 33911578; PMCID: PMC7992685.
Manchanda Y, Ramamoorthy R. Revisiting pediatric alopecia areata: newer insights. Indian J Paediatr Dermatol. 2021;22(4):301-5. DOI: 10.4103/ijpd.ijpd_109_21.
Conic RZ, Tamashunas NL, Damiani G, et al; Young Dermatologists Italian Network. Comorbidities in pediatric alopecia areata. J Eur Acad Dermatol Venereol. 2020;34(12):2898-901. DOI: 10.1111/jdv.16727. PMID: 32531131.
Dündar B, Boyacı A, Sangün Ö, Dündar N, Çocuk ve ergenlerde Hashimoto tiroiditi: klinik ve laboratuvar bulgularının değerlendirilmesi. Turk Pediatri Ars. 2011;46(4):318-22.DOI: 10.4274/tpa.358.1338
Casto C, Pepe G, Li Pomi A, Corica D, Aversa T, Wasniewska M. Hashimoto's thyroiditis and Graves' disease in genetic syndromes in pediatric age. Genes (Basel). 2021;12(2):222. DOI: 10.3390/genes12020222. PMID: 33557156; PMCID: PMC7913917.
Bilgiç Ö, Bilgiç A, Bahalı K, Bahali AG, Gürkan A, Yılmaz S. Psychiatric symptomatology and health-related quality of life in children and adolescents with alopecia areata. J Eur Acad Dermatol Venereol. 2014;28(11):1463-8. DOI: 10.1111/jdv.12315. PMID: 24237476.
Savarino G, Corsello A, Corsello G. Macronutrient balance and micronutrient amounts through growth and development. Ital J Pediatr. 2021;47(1):109. DOI: 10.1186/s13052-021-01061-0. PMID: 33964956; PMCID: PMC8106138.
Silverberg N. The genetics of pediatric cutaneous autoimmunity: the sister diseases vitiligo and alopecia areata. Clin Dermatol. 2022;40(4):363-73. DOI: 10.1016/j.clindermatol.2022.02.009. PMID: 35183681.
Lu YY, Wu MK, Lu CC, Wang WT, Wu CH. Atopic diseases and the risk of alopecia areata among pre-teens and teenagers in Taiwan. Indian J Dermatol Venereol Leprol. 2024;90:1-6. DOI: 10.25259/IJDVL_1215_2023. PMID: 39152872
Nawani S, Satyasri T, Netha GN, Rammohan G, Kumar B. Autoimmune associations of alopecia areata in pediatric population: a study in a tertiary care centre. Indian J Clin Exp Dermatol. 2020;6(2):97-101. DOI: 10.18231/j.ijced.2020.010.
Pratt CH, King LE Jr, Messenger AG, Christiano AM, Sundberg JP. Alopecia areata. Nat Rev Dis Primers. 2017;3:17011. DOI: 10.1038/nrdp.2017.11. PMID: 28300084; PMCID: PMC5573125.
Türkay A, Uzunçakmak TK, Engin B, Serdaroğlu S. Alopecia areata: current review. Dermatoz. 2020;11(4):39-51. DOI: 10.4274/dermatoz.galenos.2021.88598.
Gürlek A, Gökçay Canpolat A, Güngüneş A, et al. Tiroid Hastalıkları Tanı ve Tedavi Kılavuzu 2023. 7th ed. Ankara: Türkiye Endokrinoloji ve Metabolizma Derneği Yayınları; 2023..
Ly S, Manjaly P, Kamal K, et al. Comorbid conditions associated with alopecia areata: a systematic review and meta-analysis. Am J Clin Dermatol. 2023;24(6):875–893. DOI: 10.1007/s40257-023-00785-7. PMID: 37723721.
Sorrell J, Petukhova L, Reingold R, et al. Shedding light on alopecia areata in pediatrics: a retrospective analysis of comorbidities in children in the National Alopecia Areata Registry. Pediatr Dermatol. 2017;34(5):e271–e272. DOI: 10.1111/pde.13238. PMID: 28834507.
Sheth VM, Guo Y, Qureshi AA. Comorbidities associated with vitiligo: a ten-year retrospective study. Dermatology. 2013;227(4):311-5. DOI: 10.1159/000354607. Epub 2013 Oct 4. PMID: 24107643.
Tissera KA, Bitar RA, Hawryluk EB, Garza-Mayers AC. Comorbidities of pediatric vitiligo. JAAD Rev. 2025;3:131–137. DOI: 10.1016/j.jdrv.2025.01.006.
Tharwat S, Hamdy F, Hamdy S, Nassar MK. Prevalence of co-existing autoimmune and autoinflammatory diseases in vitiligo: a survey-based study from Egypt. BMC Rheumatol. 2024;8(1):59. DOI: 10.1186/s41927-024-00427-1. PMID: 39501366
Rork JF, Rashighi M, Harris JE. Understanding autoimmunity of vitiligo and alopecia areata. Curr Opin Pediatr. 2016;28(4):463–469. DOI: 10.1097/MOP.0000000000000375. PMID: 27191524
Damsky W, King BA. JAK inhibitors in dermatology: the promise of a new drug class. J Am Acad Dermatol. 2017;76(4):736–744. DOI: 10.1016/j.jaad.2016.12.005. PMID: 28139263
Ali NS, Tollefson MM, Lohse CM, Torgerson RR. Incidence and comorbidities of pediatric alopecia areata: a retrospective matched cohort study using the Rochester Epidemiology Project. J Am Acad Dermatol. 2022;87(2):427–429. DOI: 10.1016/j.jaad.2021.08.050. PMID: 34474151. PMCID: PMC9117776.
Paller A, Jaworski JC, Simpson EL, et al. Major Comorbidities of Atopic Dermatitis: Beyond Allergic Disorders. Am J Clin Dermatol. 2018 Dec;19(6):821-838. DOI: 10.1007/s40257-018-0383-4. PMID: 30168085.
Geng RSQ, Buhler KA, Choi MY, et al. Serum Th1, Th2, Th17, and innate immune system biomarkers are elevated in pediatric alopecia areata with and without concurrent atopic dermatitis: A cross-sectional study. JAAD Int. 2024;18:128-30. DOI: 10.1016/j.jdin.2024.09.008. PMID: 39719961; PMCID: PMC11667068.
Montilla AM, Gómez-García F, Gómez-Arias PJ, et al.Review on the use of drugs targeting JAK/STAT pathway in atopic dermatitis, vitiligo, and alopecia areata. Dermatol Ther (Heidelb). 2019;9(4):655–683. DOI: 10.1007/s13555-019-00329-y. PMID: 31655972.
Zhou W, Cai J, Li Z, Lin Y. Association of atopic dermatitis with autoimmune diseases: a bidirectional and multivariable two-sample Mendelian randomization study. Front Immunol. 2023;14:1132719. DOI: 10.3389/fimmu.2023.1132719. PMID: 37065076. PMCID: PMC10097009.
Lusignan S, Alexander H, Broderick C, et al. Atopic dermatitis and risk of autoimmune conditions: population-based cohort study. J Allergy Clin Immunol. 2022;150(3):709–713. DOI: 10.1016/j.jaci.2022.03.030. PMID: 35460663.
Wohlmuth-Wieser I, Osei JS, Norris D, et al. Childhood alopecia areata: data from the National Alopecia Areata Registry. Pediatr Dermatol. 2018;35(2):164–169. DOI: 10.1111/pde.13387. PMID: 29380454.
Lu YY, Wu MK, Lu CC, Wang WT, Wu CH. Atopic diseases and the risk of alopecia areata among pre-teens and teenagers in Taiwan. Indian J Dermatol Venereol Leprol. 2024;90:1–6. DOI: 10.25259/IJDVL_1215_2023. PMID: 39152872
Serarslan G, Savaş N, Yenin JZ. Is atopy and autoimmunity more prevalent in patients with alopecia areata? A comparative study. J Eur Acad Dermatol Venereol. 2012 Jun;26(6):720-3. DOI: 10.1111/j.1468-3083.2011.04152.x. Epub 2011 Jun 21. PMID: 21692870.
Kridin K, Renert-Yuval Y, Guttman-Yassky E, Cohen AD. Alopecia areata is associated with atopic diathesis: results from a population-based study of 51,561 patients. J Allergy Clin Immunol Pract. 2020;8(4):1323-1328.e1. DOI: 10.1016/j.jaip.2020.01.052. PMID: 32032694.
Campos-Alberto E, Hirose T, Napatalung L, Ohyama M. Prevalence, comorbidities, and treatment patterns of Japanese patients with alopecia areata: A descriptive study using Japan medical data center claims database. J Dermatol. 2023 Jan;50(1):37-45. DOI: 10.1111/1346-8138.16615. Epub 2022 Nov 2. PMID: 36321512; PMCID: PMC10092019..
Xu W, Zhang H, Wan S, Xie B, Song X. Genetic links between atopy, allergy, and alopecia areata: insights from a Mendelian randomization study. Allergy Asthma Clin Immunol. 2024;20(1):32. DOI: 10.1186/s13223-024-00892-w. PMID: 38704164.
Ghanizadeh A. Comorbidity of psychiatric disorders in children and adolescents with alopecia areata in a child and adolescent psychiatry clinical sample. Int J Dermatol. 2008;47(11):1118–1120. DOI: 10.1111/j.1365-4632.2008.03743.x. PMID: 19076668.
Altunisik N, Ucuz I, Turkmen D. Psychiatric basics of alopecia areata in pediatric patients: Evaluation of emotion dysregulation, somatization, depression, and anxiety levels. J Cosmet Dermatol. 2022;21(2):770–775. DOI: 10.1111/jocd.14122. PMID: 34888986.
Lauron S, Plasse C, Vaysset M, et al. Prevalence and odds of depressive and anxiety disorders and symptoms in children and adults with alopecia areata: A systematic review and meta-analysis. JAMA Dermatol. 2023;159(3):281–288. DOI: 10.1001/jamadermatol.2022.6085. PMID: 36786747.
Ho HY, Wong CK, Wu SY, Hsiao RC, Chen YL, Yen CF. Increased alopecia areata risk in children with attention-deficit/hyperactivity disorder and the impact of methylphenidate use: a nationwide population-based cohort study. Int J Environ Res Public Health. 2021;18(3):1286. DOI: 10.3390/ijerph18031286. PMID: 33535410.
Ji C, Liu S, Zhu K, Luo H, Li Q, Zhang Y, et al.HLA-DRB1 polymorphisms and alopecia areata disease risk. Medicine (Baltimore). 2018;97(30):e11790. DOI: 10.1097/MD.0000000000011790. PMID: 30045340.
Aureli A, Sebastiani P, Del Beato T, et al.Investigation on the possible relationship existing between the HLA-DR gene and attention deficit hyperactivity disorder and/or mental retardation. Int J Immunopathol Pharmacol. 2008;21(4):985–991. DOI: 10.1177/039463200802100423. PMID: 19144216.
Danielson ML, Claussen AH, Bitsko RH, et al. ADHD prevalence among U.S. children and adolescents in 2022: diagnosis, severity, co-occurring disorders, and treatment. J Clin Child Adolesc Psychol. 2024;53(3):343-60. DOI: 10.1080/15374416.2024.2335625. PMID: 38778436; PMCID: PMC11334226.
Jangmo A, Stålhandske A, Chang Z, et al. Attention-deficit/hyperactivity disorder, school performance, and effect of medication. J Am Acad Child Adolesc Psychiatry. 2019;58(4):423–432. DOI: 10.1016/j.jaac.2018.11.014. PMID: 30768391; PMCID: PMC6541488.
Rado F. Review study on attention deficit and hyperactivity disorder. Pearson J Soc Sci Humanit. 2024;1615:1624. DOI: 10.5281/zenodo.13628871.
Abdaljawad S, Qiteesh H, Abdelgader A, Saed W. Serum ferritin level and alopecia areata in pediatric patients. AlQalam J Med Appl Sci. 2022;5(2):527–533. DOI: 10.5281/zenodo.7264077.
Arosio P, Ingrassia R, Cavadini P. Ferritins: a family of molecules for iron storage, antioxidation and more. Biochim Biophys Acta. 2009;1790(7):589–599. DOI: 10.1016/J.BBAGEN.2008.09.004. PMID: 18930140.
Kundak S, Kutlu A. Serum 25-Hydroxy-Vitamin D and Vitamin B12 levels in childhood alopecia areata. J Dr Behcet Uz Child Hosp. 2021;11(1):101–107. DOI: 10.5222/buchd.2021.42744.
Ertugrul DT, Taner D, Takci Z et al. Serum holotranscobalamine, vitamin B12, folic acid and homocysteine levels in alopecia areata patients. Cutan Ocul Toxicol. 2013;32(1):1-3. DOI: 10.3109/15569527.2012.689443. PMID: 22591107.
Gonul M, Cakmak SK, Soylu S, et al. Serum vitamin B12, folate, ferritin, and iron levels in Turkish patients with alopecia areata. Indian J Dermatol Venereol Leprol. 2009;75(5):552. DOI: 10.4103/0378-6323.55430. PMID: 19736464.
Varkal MA. Genel pediatri polikliniği vakalarında B12 vitamini eksikliği. Çocuk Dergisi. 2022;22(1):15–20. DOI: 10.26650/jchild.2021.956537.
Krugluger W, Stiefsohn K, Laciak K, et al. Vitamin B12 activates the Wnt-pathway in human hair follicle cells by induction of β-catenin and inhibition of glycogen synthase kinase-3 transcription. J Cosmet Dermatol Sci Appl. 2011;1:25–29. DOI: 10.4236/jcdsa.2011.12004.
Van de Lagemaat EE, de Groot LCPGM, van den Heuvel EGHM. Vitamin B12 in Relation to Oxidative Stress: A Systematic Review. Nutrients. 2019 Feb 25;11(2):482. DOI 10.3390/nu11020482. PMID: 30823595; PMCID: PMC6412369.
Mikkelsen K, Apostolopoulos V. Vitamin B12, folic acid, and the immune system. In: Chatterjee S, Jungraithmayr W, Bagchi D, eds. Nutrition and Immunity. Cham: Springer; 2019:103-114. DOI: 10.1007/978-3-030-16073-9_7.
Kurtev A, Iliev E. Thyroid autoimmunity in children and adolescents with alopecia areata. Int J Dermatol. 2005 Jun;44(6):457-61. DOI:10.1111/j.1365-4632.2005.01971.x. PMID: 15941439.
Zhao Y, Guo F, Guo M. Thyroid Dysfunction and Alopecia Areata: A Genetic Prediction Causality Analysis Study. Skin Res Technol. 2024;30(10):e70063. DOI:10.1111/srt.7006
Lee S, Lee H, Lee CH, Lee WS. Comorbidities in alopecia areata: A systematic review and meta-analysis. J Am Acad Dermatol. 2019;80(2):466-477.e16. DOI:10.1016/j.jaad.2018.07.013
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Seçil Yigen Iritaş
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.
How to Cite
Share
